Literature DB >> 7562014

In vitro and in vivo antimicrobial action of fluphenazine.

S G Dastidar1, A Chaudhury, S Annadurai, S Roy, M Mookerjee, A N Chakrabarty.   

Abstract

The antipsychotic drug fluphenazine was obtained in a dry powder form and was screened with respect to 482 strains of bacteria, which included 170 Gram-positive and 326 Gram-negative strains. Nutrient agar plates containing increasing concentrations of fluphenazine (0-200 micrograms/ml) were used for the determination of the minimum inhibitory concentration (MIC) which was demonstrated by inoculating a loopful of an overnight peptone water culture of the organism on nutrient agar plates and determining the MIC against a control. Fluphenazine was detected to possess pronounced action against both Gram-positive and Gram-negative bacteria at 20-100 micrograms/ml. In the in vivo studies it was seen that when fluphenazine was used at a concentration of 1.5 micrograms/g and 3 micrograms/g mouse body weight both the levels offered significant protection to Swiss strain of white mice when challenged with 50 minimum lethal dose (MLD) of a virulent strain of Salmonella typhimurium 74. The in vivo data with fluphenazine were highly significant (p < 0.001) according to the chi-square test.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562014     DOI: 10.1179/joc.1995.7.3.201

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  9 in total

1.  Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.

Authors:  L Jeyaseeli; A Dasgupta; S G Dastidar; J Molnar; L Amaral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

Review 2.  The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target.

Authors:  K Mazumdar; S G Dastidar; J H Park; N K Dutta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-28       Impact factor: 3.267

Review 3.  Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Authors:  Q R Ducarmon; R D Zwittink; B V H Hornung; W van Schaik; V B Young; E J Kuijper
Journal:  Microbiol Mol Biol Rev       Date:  2019-06-05       Impact factor: 11.056

4.  Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity.

Authors:  Hassan Nehme; Patrick Saulnier; Alyaa A Ramadan; Viviane Cassisa; Catherine Guillet; Matthieu Eveillard; Anita Umerska
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

Review 5.  Psychotropics and the Microbiome: a Chamber of Secrets….

Authors:  Sofia Cussotto; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2019-02-26       Impact factor: 4.530

6.  Antibacterial Effect of Diclofenac Sodium on Enterococcus faecalis.

Authors:  Amin Salem-Milani; Esrafil Balaei-Gajan; Saeed Rahimi; Zohreh Moosavi; Ardalan Abdollahi; Parvin Zakeri-Milani; Mehrdad Bolourian
Journal:  J Dent (Tehran)       Date:  2013-01-31

7.  A comparative analysis of in vitro and in vivo efficacies of the enantiomers of thioridazine and its racemate.

Authors:  Jørn B Christensen; Oliver Hendricks; Shaswati Chaki; Sayanti Mukherjee; Ayan Das; Tapan K Pal; Sujata G Dastidar; Jette E Kristiansen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

8.  An Investigation on in vitro and in vivo Antimicrobial Properties of the Antidepressant: Amitriptyline Hydrochloride.

Authors:  Anurup Mandal; Chandrima Sinha; Aditya Kumar Jena; Soma Ghosh; Amalesh Samanta
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

9.  Is there a role of faecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and Meta-analysis.

Authors:  Priyanga Dharmaratne; Nannur Rahman; Anthony Leung; Margaret Ip
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.